Delay of antiretroviral therapy initiation is common in east African HIV-infected individuals in serodiscordant partnerships

Journal of Acquired Immune Deficiency Syndromes

Volumn 66, Issue 4, 2014, Pages 436-442

  Mujugira, Andrew ^a   Celum, Connie ^a   Thomas, Katherine K ^a   Farquhar, Carey ^a   Mugo, Nelly ^a,b   Katabira, Elly ^c   Bukusi, Elizabeth A ^a,b   Tumwesigye, Elioda ^d   Baeten, Jared M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c MAKERERE UNIVERSITY   (Uganda)

^d Kabwohe Clinical Research Centre   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; COTRIMOXAZOLE;

ADULT; AFRICA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HEALTH CARE ACCESS; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; KENYA; MAJOR CLINICAL STUDY; MALE; MONITORING; MULTICENTER STUDY; PATIENT CARE; PATIENT COUNSELING; PATIENT REFERRAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY DELAY; UGANDA;

ADULT; AFRICA, EASTERN; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HUMANS; KENYA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SEXUAL PARTNERS; YOUNG ADULT;

EID: 84903758855     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000192     Document Type: Article

References (26)

1. WHO. Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards Universal Access. Geneva: WHO; 2011. Progress report
2. WHO. The 3 by 5 Initiative. Geneva, Switzerland: WHO; Available at: http://www.who.int/3by5/en.2005. Accessed September 6, 2013
3. WHO. Guidance on Couples HIV Testing and Counselling Including Antiretroviral Therapy for Treatment and Prevention in Serodiscordant Couples. Geneva, Switzerland: World Health Organization; 2012
4. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505
5. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8: e1001056
6. Clouse K, Pettifor AE, Maskew M, et al. Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2013;62:e39-e46
7. McGrath N, Glynn JR, Saul J, et al. What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi. BMC Public Health. 2010;10:601
8. Micek MA, Gimbel-Sherr K, Baptista AJ, et al. Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr. 2009;52:397-405
9. Losina E, Bassett IV, Giddy J, et al. The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One. 2010;5:e9538
10. Geng EH, Bangsberg DR, Musinguzi N, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr. 2010;53:405-411
11. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New Engl J Med. 2012;367: 399-410
12. Mujugira A, Baeten JM, Donnell D, et al. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. PLoS One. 2011;6: e25828
13. Mugglin C, Estill J, Wandeler G, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2012;17(12):1509-1520
14. Hanna DB, Buchacz K, Gebo KA, et al. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001- 2009. Clin Infect Dis. 2013;56:1174-1182
15. Bassett IV, Wang B, Chetty S, et al. Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr. 2009;51:135-139
16. Parkes-Ratanshi R, Bufumbo L, Nyanzi-Wakholi B, et al. Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment. Trop Med Int Health. 2010;15:1347-1356
17. Fleishman JA, Yehia BR, Moore RD, et al. Disparities in receipt of antiretroviral therapy among HIV-infected adults (2002-2008). Med Care. 2012;50:419-427
18. Opadina F. Living positively with HIV. Afr Health. 1995;17:35
19. Katz IT, Essien T, Marinda ET, et al. Antiretroviral Refusal among Newly Diagnosed HIV-infected adults in Soweto, South Africa. AIDS. 2011;25:2177-2181
20. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26:2059-2067
21. Siedner MJ, Lankowski A, Haberer JE, et al. Rethinking the "pre" in pretherapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One. 2012;7: e39894
22. Malone JL, Simms TE, Gray GC, et al. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr. 1990;3:144-151. (Pubitemid 20080777)
23. Guthrie BL, Choi RY, Liu AY, et al. Barriers to antiretroviral initiation in HIV-1-discordant couples. J Acquir Immune Defic Syndr. 2011;58(3): e87-93
24. Fox MP, Mazimba A, Seidenberg P, et al. Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: a crosssectional study of cost, stigma, and perceptions about ART. J Int AIDS Soc. 2010;13:8
25. Heffron R, Ngure K, Mugo N, et al. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral based HIV-1 prevention strategies. J Acquir Immune Defic Syndr. 2012;61(1):116-119
26. Kahn TR, Desmond M, Rao D, et al. Delayed initiation of antiretroviral therapy among HIV-discordant couples in Kenya. AIDS Care. 2013;25: 265-272